Responsibility for our products

Our success and our future are founded on innovative products that benefit people and help improve quality of life. Furthermore, through many of our products, we are helping to overcome global challenges such as climate change, energy scarcity and access to health.

Our products are highly trusted worldwide - whether our innovative medicines of chemical or biological origin, our over-the-counter products, our liquid crystals for LC displays, our pigments for the coatings, plastics and printing industries, products for the cosmetics industry, or customer-oriented lab solutions for the life science industry.
Responsibility for our products will always be at the heart of our corporate responsibility. Here, we are driven by our ethical standards as well as our high expectations in terms of safety and environmental compatibility.
Extensive information for patients
We believe that worldwide access to medicinal product information is one of the keys to improving health care for patients. We recognize the important role that patient organizations play in disseminating information to patients and their caregivers. This is why we support the educational work of various patient organizations with donations and funding. Our company explicitly endeavors to exert no influence or control over the information that the organizations communicate to their members. For complete transparency, we publish our donations to European patient organizations on our website and update the information annually.
Promoting research
In order to drive medical advancements, our company promotes science and advanced medical training across the globe. For instance, within the scope of international initiatives, we award grants in the fields of infertility (Grant for Fertility Innovation), multiple sclerosis (Grant for Multiple Sclerosis Innovation), personalized therapy for solid tumors (Grant for Oncology Innovation), and growth disorders (Grant for Growth Innovation). Through contributions to numerous providers of advanced medical training, we are also helping develop and provide independent advanced medical training for scientists, nursing staff, pharmacists, and other health care practitioners.
Our company also supports the health industry through donations of money and supplies. Recipients include organizations such as medical science professional associations, hospitals and university clinics. This support is a reflection of our values, and the contributions are not intended to influence decisions regarding treatment, prescriptions or purchasing.


Publication of Merck KGaA, Darmstadt, Germany.
In the United States and Canada the subsidiaries of Merck KGaA, Darmstadt, Germany operate under the umbrella brand EMD. To reflect such fact and to avoid any misconception of the reader of the publication certain logos, terms and business descriptions of the publication have been substituted or additional descriptions have been added. Publications on this homepage, therefore, slightly deviate from the otherwise identical version of the publications provided outside the United States and Canada.
Read more on M - The Explorer Magazine

A world-renowned baby

Elizabeth Carr was America’s first test-tube baby. A medicine from our company helped make her sensational birth possible in 1981. Elizabeth was followed by millions of other babies.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Bike MS: Riding for a good cause

Cycling with a long tradition: The Cape Cod Getaway (CCG) will take place for the 11th time at the end of June. The event is part of the Bike MS® fundraising cycling series.

Read more on M - The Explorer Magazine
Read more on M - The Explorer Magazine

Discovering the New World

An innovation-friendly environment and business opportunities — the preconditions for success are more favorable in the United States than just about anywhere else.

Read more on M - The Explorer Magazine